See also this year's filing and all EDGAR filings for this company.
PDF Report 0001131675_2013_Hasco_Medical_Inc.pdf
Logs
warning | The stock price does not exist | industry.us_generic | {} |
warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
warning | No stock price available | subcommand.plot | {} |
warning | Missing logo | subcommand.report | {} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001131675')"} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001131675')"} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
Graph
Absolute values for 0001131675, Hasco Medical Inc
xvar | xval | |
---|---|---|
0 | LiabilitiesCurrent | 18,040,113 |
1 | LiabilitiesNoncurrent | 0 |
2 | remainder_Liabilities | 6,390,607 |
3 | AssetsCurrent | 18,891,112 |
4 | AssetsNoncurrent | 24,239 |
5 | PropertyPlantAndEquipmentNet | 1,521,267 |
6 | Goodwill | 7,277,644 |
7 | remainder_Assets | 0 |
8 | CostOfGoodsAndServicesSold | 0 |
9 | SellingGeneralAndAdministrativeExpense | 0 |
10 | ResearchAndDevelopmentExpense | 0 |
11 | remainder_Expenses | 63,074,217 |
12 | remainder_Revenues | 63,852,766 |
13 | remainder_NetIncome | -376,641 |
14 | remainder_ComprehensiveNetIncome | 0 |
yvar | yval | |
---|---|---|
0 | Liabilities | 24,430,720 |
1 | Assets | 27,714,262 |
2 | Expenses | 63,074,217 |
3 | Revenues | 63,852,766 |
4 | StockholdersEquity | 3,283,542 |
5 | NetIncome | 401,908 |
6 | ComprehensiveNetIncome | 401,908 |
7 | BaseVar | 89,724,303 |
8 | EconomicCapitalRatiobeforeLimitedLiability | 0.138 |
9 | EconomicCapitalRatio | 0.782 |